Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elham Rayzan, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Heidari-Foroozan M, Saeedi Moghaddam S, Keykhaei M, Shobeiri P, Azadnajafabad S, Esfahani Z, Rezaei N, Nasserinejad M, Rezaei N, Rayzan E, Shokri Varniab Z, Golestani A, Haghshenas R, Kompani F, Larijani B, Farzadfar F. Regional and national burden of leukemia and its attributable burden to risk factors in 21 countries and territories of North Africa and Middle East, 1990-2019: results from the GBD study 2019. J Cancer Res Clin Oncol. 2022 Sep 01. PMID: 36048271.
    Citations:    Fields:    
  2. Aminorroaya A, Rayzan E, Shahkarami S, Seyedpour S, Zoghi S, Aryan Z, Somekh I, Rohlfs M, Klein C, Esmaeilzadeh H, Rezaei N. Novel DNMT3B Mutation in a Patient with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome and a Bronchopulmonary Collateral Artery. Endocr Metab Immune Disord Drug Targets. 2022 Aug 22. PMID: 35996251.
    Citations:    Fields:    
  3. Arab F, Rezaei N, Taheri F, Kouhpeikar H, Rayzan E, Mirbeyk M, Zare-Abdollahi D, Ghadami M. The Clinical and Molecular Assessment of Iranian Families with Severe Congenital Neutropenia, Identification of HYOU1 and SHOC2 as Potential Novel Gene Defects. Iran J Allergy Asthma Immunol. 2022 Jun 18; 21(3):344-354. PMID: 35822684.
    Citations:    Fields:    Translation:Humans
  4. Bahreini F, Rayzan E, Rezaei N. MicroRNAs and Diabetes Mellitus Type 1. Curr Diabetes Rev. 2022; 18(2):e021421191398. PMID: 33588736.
    Citations:    Fields:    Translation:Humans
  5. Sadeghmousavi S, Shahkarami S, Rayzan E, Ahmed S, Gharalari FH, Rohlfs M, Klein C, Rezaei N. A 3-Year-Old Boy with an Xp21 Deletion Syndrome: A Case Report. Endocr Metab Immune Disord Drug Targets. 2022; 22(8):881-887. PMID: 35105298.
    Citations:    Fields:    Translation:HumansCells
  6. Momtazmanesh S, Rayzan E, Zoghi S, Shahkarami S, Molatefi R, Mohammadzadeh I, Ghaffari J, Mahmoudi H, Dmytrus J, Segarra-Roca A, Somekh I, Witzel M, Hauck F, Boztug K, Klein C, Rezaei N. Novel Variants of DOCK8 Deficiency in a Case Series of Iranian Patients. Endocr Metab Immune Disord Drug Targets. 2022; 22(1):159-168. PMID: 33634762.
    Citations:    Fields:    Translation:Humans
  7. Danandeh K, Jabbari P, Rayzan E, Zoghi S, Shahkarami S, Heredia RJ, Krolo A, Shamsian BS, Boztug K, Rezaei N. Case Report of a Novel NFkB Mutation in a Lymphoproliferative Disorder Patient. Endocr Metab Immune Disord Drug Targets. 2022; 22(10):1040-1046. PMID: 35392793.
    Citations:    Fields:    Translation:Humans
  8. Kirschbaum TK, Theilmann M, Sudharsanan N, Manne-Goehler J, Lemp JM, De Neve JW, Marcus ME, Ebert C, Chen S, Aryal KK, Bahendeka SK, Norov B, Damasceno A, Dorobantu M, Farzadfar F, Fattahi N, Gurung MS, Guwatudde D, Labadarios D, Lunet N, Rayzan E, Saeedi Moghaddam S, Webster J, Davies JI, Atun R, Vollmer S, Bärnighausen T, Jaacks LM, Geldsetzer P. Targeting Hypertension Screening in Low- and Middle-Income Countries: A Cross-Sectional Analysis of 1.2 Million Adults in 56 Countries. J Am Heart Assoc. 2021 07 06; 10(13):e021063. PMID: 34212779.
    Citations: 1     Fields:    Translation:Humans
  9. Shaka Z, Mojtabavi H, Rayzan E, Zoghi S, Shahkarami S, Raul JH, Sedighi I, Boztug K, Rezaei N. Novel BTK mutation in X-linked agammaglobulinemia: Report of a 17-year-old male. Allergol Immunopathol (Madr). 2021; 49(2):80-83. PMID: 33641298.
    Citations: 1     Fields:    Translation:Humans
  10. Rezaei N, Ashkevarian S, Fathi MK, Hanaei S, Kolahchi Z, Ladi Seyedian SS, Rayzan E, Sarzaeim M, Vahed A, Mohamed K, Momtazmanesh S, Moradian N, Pirkoohi ZR, Sameeifar N, Yousefpour M, Sargoli S, Adiban S, Vahed A, Yazdanpanah N, Ziaei H, Saghazadeh A. Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge. Adv Exp Med Biol. 2021; 1318:1-22. PMID: 33973169.
    Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
  11. Maroufi SF, Shaka Z, Mojtabavi H, Sadeghalvad M, Rayzan E, Sedighi I, Shahkarami S, Najafi M, Rohlfs M, Klein C, Rezaei N. Novel G6PC3 Mutations in Patients with Congenital Neutropenia: Case Reports and Review of the Literature. Endocr Metab Immune Disord Drug Targets. 2021; 21(9):1660-1668. PMID: 34137364.
    Citations:    Fields:    Translation:Humans
  12. Taghavi-Farahabadi M, Mahmoudi M, Mahdaviani SA, Baghaei K, Rayzan E, Hashemi SM, Rezaei N. Improving the function of neutrophils from chronic granulomatous disease patients using mesenchymal stem cells' exosomes. Hum Immunol. 2020 Oct - Nov; 81(10-11):614-624. PMID: 32891471.
    Citations: 2     Fields:    Translation:HumansCells
  13. Mobasheri T, Rayzan E, Shabani M, Hosseini M, Mahmoodi Chalbatani G, Rezaei N. Neuroblastoma-targeted nanoparticles and novel nanotechnology-based treatment methods. J Cell Physiol. 2021 03; 236(3):1751-1775. PMID: 32735058.
    Citations: 1     Fields:    Translation:HumansAnimals
  14. Bahreini F, Rayzan E, Rezaei N. microRNA-related single-nucleotide polymorphisms and breast cancer. J Cell Physiol. 2021 03; 236(3):1593-1605. PMID: 32716070.
    Citations: 6     Fields:    Translation:Humans
  15. Rahmani F, Rayzan E, Rahmani MR, Shahkarami S, Zoghi S, Rezaei A, Aryan Z, Najafi M, Rohlfs M, Jeske T, Aflatoonian M, Chavoshzadeh Z, Farahmand F, Motamed F, Rohani P, Alimadadi H, Mahdaviani A, Mansouri M, Tavakol M, Vanderberg M, Kotlarz D, Klein C, Rezaei N. Clinical and Mutation Description of the First Iranian Cohort of Infantile Inflammatory Bowel Disease: The Iranian Primary Immunodeficiency Registry (IPIDR). Immunol Invest. 2021 May; 50(4):445-459. PMID: 32633164.
    Citations: 2     Fields:    Translation:Humans
  16. Momtazmanesh S, Rayzan E, Shahkarami S, Rohlfs M, Klein C, Rezaei N. A novel VPS13B mutation in Cohen syndrome: a case report and review of literature. BMC Med Genet. 2020 06 30; 21(1):140. PMID: 32605629; PMCID: PMC7325105.
    Citations: 7     Fields:    Translation:Humans
  17. Khanmohammadi S, Shabani M, Tabary M, Rayzan E, Rezaei N. Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms. Crit Rev Oncol Hematol. 2020 Jun; 150:102945. PMID: 32353704.
    Citations: 4     Fields:    Translation:Humans
  18. Rayzan E, Pouladfar G, Parvaneh N, Shahrooei M, Aryan Z, Rezaei N. Novel CYBA mutation in a family with BCGitis. Acta Microbiol Immunol Hung. 2019 Dec 18; 67(1):56-60. PMID: 31847541.
    Citations:    Fields:    Translation:Humans
  19. Mahalleh M, Shabani M, Rayzan E, Rezaei N. Reinforcing the primary immunotherapy modulators against acute leukemia; monoclonal antibodies in AML. Immunotherapy. 2019 12; 11(18):1583-1600. PMID: 31841068.
    Citations: 3     Fields:    Translation:HumansCells
  20. Amirzadegan A, Ghaderpanah R, Rayzan E, Aminorroaya A, Tajdini M. Coronary slow flow phenomenon and microalbuminuria: Is there any relationship? Turk Kardiyol Dern Ars. 2019 Dec; 47(8):657-661. PMID: 31802772.
    Citations: 1     Fields:    Translation:Humans
  21. Mahmoudi M, Taghavi-Farahabadi M, Namaki S, Baghaei K, Rayzan E, Rezaei N, Hashemi SM. Exosomes derived from mesenchymal stem cells improved function and survival of neutrophils from severe congenital neutropenia patients in vitro. Hum Immunol. 2019 Dec; 80(12):990-998. PMID: 31706743.
    Citations: 9     Fields:    Translation:HumansCells
  22. Khosravani-Rudpishi M, Joharimoghadam A, Rayzan E. The significant coronary tortuosity and atherosclerotic coronary artery disease; What is the relation? J Cardiovasc Thorac Res. 2018; 10(4):209-213. PMID: 30680079; PMCID: PMC6335987.
    Citations: 3     
  23. Nouri Rouzbahani F, Shirkhoda M, Memari F, Dana H, Mahmoodi Chalbatani G, Mahmoodzadeh H, Samarghandi N, Gharagozlou E, Mohammadi Hadloo MH, Maleki AR, Sadeghian E, Nia E, Nia N, Hadjilooei F, Rezaeian O, Meghdadi S, Miri S, Jafari F, Rayzan E, Marmari V. Immunotherapy a New Hope for Cancer Treatment: A Review. Pak J Biol Sci. 2018; 21(3):135-150. PMID: 30187723.
    Citations: 12     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Rayzan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (116)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.